Draft pharma policy: Old wine in a new bottle?
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing 'more…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Editor’s note
Surviving serialisation
It was way back in 1963 that the US FDA finalised the first version of Good Manufacturing Practices (GMPs) for finished…
India Pharma Inc’s tryst with destiny continues
As we mark our 71st Independence Day this August 15, how far have we progressed on the medicines security front?
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…
Racing against the GST deadline
The May update on pharma channel sales was gloomy at best, according to AIOCD PharmaTrac
Dull Q4FY17 could be a blessing in disguise
According to a report from CARE Ratings on the corporate performance of Q4FY17, the pharmaceuticals and drugs sector in India,…
Towards sustainability
Sustainability measures achieve the twin benefits of reducing operating costs while simultaneously meeting environmental goals
Bridging the skills gap
Beleaguered by warning letters and import recalls, pharmaceutical companies in India seem to be finally investing in upskilling…
Passing the buck?
Prime Minister Modi’s announcement that his government would ensure doctors prescribed generic medicines stirred a hornet’s nest
Does IP build or block?
Its been 17 years since the World Intellectual Property Organisation (WIPO) started marking April 26 as World Intellectual…
US-India relationship: Can it trump the odds?
Affordable and efficient healthcare systems is listed out as an area chosen for “Growing Convergence, Collaboration &…
Collaborate to conquer
Two rulings in the space of as many days demonstrate the fine balance required of India’s legal system when it comes to the…
Evolving an ‘India First’ policy
The countdown to the USTR for 2017 Special 301 Review has begun
Beyond the budget
The hype around the Union Budget 2017-18, especially after Prime Minister Modi's December 31 address was high but the general…
Pharma PSUs: Missed opportunity?
The turnover of the Indian pharmaceutical industry was estimated at Rs 2,04,627.1 crores in FY2015-16, registering a growth of 29…
Giving with a purpose
‘He who has health, has hope; and he who has hope, has everything,’ said Thomas Carlyle, social commentator and philosopher
More pain before the gain
An ICRA quarter update on the pharmaceutical sector does not have very encouraging news for 2017
Girding up for a VUCA world
The term VUCA, an acronym for volatility, uncertainty, complexity and ambiguity, was reportedly first coined by the US Army War…
More power to GST
The ongoing winter session of Parliament is crucial as there are many big ticket bills awaiting a nod
India Pharma Inc’s Trump card
Donald J Trump has beaten all odds to win the US election, much like the Indian pharmaceutical industry’s hard won rise as the…